Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Change in Inventory (2024 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Change in Inventory for 2 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 93.18% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.0 million through Dec 2025, up 8.54% year-over-year, with the annual reading at $37.0 million for FY2025, 8.54% up from the prior year.
  • Change in Inventory for Q4 2025 was $1.7 million at Madrigal Pharmaceuticals, down from $5.8 million in the prior quarter.
  • The five-year high for Change in Inventory was $25.4 million in Q4 2024, with the low at $854000.0 in Q1 2024.